Print
PDF

Barts Cancer Institute at St Bartholomew’s Hospital
Summer 2012 Seminar Programme
All seminars will take place on Wednesday at 5pm unless otherwise stated.
Please see the information box on the right for venue and contact information.

DATE SPEAKER TITLE

09-May

Prof Stephen Devereux
Consultant Haematologist &
Professor of Lymphoma Biology
Division of Cancer Studies
King's College London 

CLL - a T cell Driven Disorder

**Note**
Friday 18-May
12.30pm
Willoughby Lecture Theatre
Charterhouse Square
EC1M 6BQ


Prof Randy Gascoyne
Hematopathologist at the BC Cancer Agency
Research Director, Centre for Lymphoid Cancers, BC Cancer Agency
Distinguished Scientist, BC Cancer Research Centre
Clinical Professor of Pathology,
University of British Columbia
Vancouver, Canada 

"Next Generation Sequencing of Lymphoid Cancers: What have we Learned?"

(Part of the BCI Distinguished Guest Lecture Series

23-May

NO SEMINAR

 

30-May

Prof Doreen Cantrell
Professor of Cellular Immunology
Wellcome Trust Principal Research Fellow
Vice Principal and Head of College
College of Life Sciences
University of Dundee 

Serine Kinases Determine Effector/Memory T Cell Fate

06-June

Dr Inas El Najjar
Centre for Haemato-Oncology
Barts Cancer Institute, QMUL

The Clinical Course of Follicular Lymphoma in the Rituximab and PET Era

**Note**
Tuesday 12-June
12.15pm
Seminar Room
3rd Floor
John Vane Science Centre
Charterhouse Square
EC1M 6BQ 

Prof Anthony Letai
Associate Professor in Medicine
Dana-Farber Cancer Institute
Harvard Medical School 

The Mitochondrion - Cancer's Crystal Ball

20-June

Prof Tessa Holyoake
Director of Paul O'Gorman Leukaemia Research Centre
Institute of Cancer Sciences
University of Glasgow 

Approaches to Eradication of CML

27-June


Prof Nick Cross
Professor of Human Genetics
University of Southampton 

Genetic Complexity of MPN and MDS

04-July

Dr Simon Hallam
Centre for Haemato-Oncology
Barts Cancer Institute, QMUL 

Exploring the Role of Tumour Associated Macrophages in Lymphoma

11-July

Prof Graham Jackson
Professor of Clinical Haematology
Newcastle University 

MRC Trials in Myeloma

18-July

Prof Charles Swanton
Cancer Research UK Group Leader
Therapeutics Laboratory
London Research Institute


Challenges of Intratumour Heterogeneity in Cancer Medicine